
Virtual Reality for Patients With Schizophrenia
VR-based training may help improve social cognition and functioning in patients with schizophrenia.
Virtual reality (VR) technology could be effective in treating patients with schizophrenia who suffer from motivational deficits and low treatment adherence. According to the preliminary findings of a recent study, VR-based social cognition and interaction training (VR-SCIT) is a promising method for improving social cognition and functioning in patients with
Researchers developed a novel VR-SCIT that combined traditional SCIT (TR-SCIT) intervention with VR technology, and compared its efficacy with that of traditional SCIT.
“VR is immersive, interactive, and dynamic, and it elicits psychological reactions that are similar to those occurring in everyday life. Therefore, it is suitable for simulating a range of social situations and accurately portraying their complexity,” wrote the study authors.1
Researchers separated 87 participants diagnosed with schizophrenia into either a VR-SCIT group or a TR-SCIT group. Findings showed that VR-SCIT had a higher
Virtual reality interventions have seen prior success in other settings aimed at evaluating and improving symptoms and functional outcomes in schizophrenia.4-8 This research indicates VR may be useful as a stand-alone or adjunct treatment for patients with schizophrenia and other psychotic diseases.9,10
“The present study provides the first evidence that VR-SCIT has the potential to improve social cognition in patients with schizophrenia,” said the authors.1 “Although preliminary, it is suggested that the SCIT program, including the VR-based format, should become part of routine clinical interventions for patients with schizophrenia.”
References
1. Shen ZH, Liu MH, Wu Y, et al.
2. Sardi L, Idri A, Fernández-Alemán JL.
3. Vajawat B, Varshney P, Banerjee D.
4. Rus-Calafell M, Garety P, Sason E, et al.
5. Park KM, Ku J, Choi SH, et al.
6. Pot-Kolder RMCA, Geraets CNW, Veling W, et al.
7. Horan B, Heckenberg R, Maruff P, Wright B.
8. Nijman SA, Veling W, Greaves-Lord K, et al.
9. Adery LH, Ichinose M, Torregrossa LJ, et al.
10. Freeman D, Reeve S, Robinson A, et al.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.















